CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Singularity AG has created an innovative Supraglottic Airway Device (SAD) that offers a safer and more versatile alternative for airway management during anesthesia. The device is designed for mass production and aims to meet the high demand for airway devices in medical settings.
Singularity AG is a medical device company created in 2012, in Zürich.
The inspiration driving the company was to design an advanced unique 2nd generation Supraglottic Airway Device (SAD).
The original design of “Singularity SAD” offers an innovative, versatile, cheaper and safer alternative compared to the current static SADs.
It avoids unnecessary risks and complications associated to insertion, maintenance and manipulation of patients under anesthesia and can be used in most situations requir…
SINGULARITY AG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
